Challenges for US Companies Entering the EU

by Michael Sassano It is very clear to most cannabis industry analysts that the United States is the undisputed heavyweight in terms of cannabis, ringing in around $13 billion in […]

The bioavailability challenges facing CBD medicines

[ad_1] With the emergence of CBD-primarily based medicines, Sarath Chandar, chief scientific officer, SPI Pharma guides readers via the bioavailability challenges facing this sector of the market. Cannabidiol, or CBD, […]

Navigating Cannabis Staffing and Hiring Challenges

[ad_1] With extra cannabis staffing and recruiting challenges than ever ahead of, developing a healthful pipeline of prime candidates can be an uphill battle. From a lack of certified candidates […]